Eli Lilly and Company (LLY)

Eli Lilly Revenue

Eli Lilly had revenue of $11.44B in the quarter ending September 30, 2024, with 20.43% growth. This brings the company's revenue in the last twelve months to $40.86B, up 27.41% year-over-year. In the year 2023, Eli Lilly had annual revenue of $34.12B with 19.56% growth.

• Revenue (ttm): $40.86B
• Revenue Growth: +27.41%
• P/S Ratio: 16.61
• Revenue / Employee: $950,309
• Employees: 43,000
• Market Cap: 678.39B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	34.12B	5.58B	19.56%
Dec 31, 2022	28.54B	223.00M	0.79%
Dec 31, 2021	28.32B	3.78B	15.40%
Dec 31, 2020	24.54B	2.22B	9.95%
Dec 31, 2019	22.32B	826.20M	3.84%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.